Lileikyte, Gabriele http://orcid.org/0000-0002-6778-6269
Bakochi, Anahita
Ali, Ashfaq
Moseby-Knappe, Marion
Cronberg, Tobias
Friberg, Hans
Lilja, Gisela
Levin, Helena
Årman, Filip
Kjellström, Sven
Dankiewicz, Josef
Hassager, Christian
Malmström, Johan
Nielsen, Niklas
Funding for this research was provided by:
Vetenskapsrådet
Hjärt-Lungfonden
AFA Försäkring
Skånes universitetssjukhus
Gyllenstiernska Krapperupsstiftelsen
Swedish National Health Service
Skåne County Council's Research and Development Foundation
Svenska Läkaresällskapet
Koch Foundation
TrygFonden
European Clinical Research Infrastructures Network
Stiftelsen Thelma Zoégas fond för medicinsk forskning
Stig and Ragna Gorthon Foundation
Stiftelsen Konsul Thure Carlssons Minne
Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse för medicinsk forskning
Hjärnfonden
Lundbeckfonden
Torsten Söderbergs Stiftelse
Lund University
Article History
Received: 5 March 2023
Accepted: 3 June 2023
First Online: 17 July 2023
Declarations
:
: The TTM trial protocol was approved by the ethical committees in each participating institution [CitationRef removed]. In Sweden, the trial was approved by the Regional Ethical Review Board in Lund 2011/117. The repository protocol was registered at ClinicalTrials.gov (NCT01020916). Written informed consent was waived or obtained from all included patients or relatives in accordance with Declaration of Helsinki and according to each participating site’s legislation.
: Not applicable.
: The authors declare that they have no competing interests.